Compile Data Set for Download or QSAR
Report error Found 289 Enz. Inhib. hit(s) with all data for entry = 12688
TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719774BDBM719774(2-hydroxy-N-((5-(2-((2-methyl-6- (trifluoromethyl)...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719775BDBM719775(N-((5-(2-((6-cyclopropoxy-2- methylquinazolin-4- y...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719772BDBM719772(2-hydroxy-N-((5-(2-((1-methyl-6- (trifluoromethyl)...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719770BDBM719770(2-hydroxy-N-((5-(2-((5- (trifluoromethyl)oxazolo[4...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719771BDBM719771(N-((5-(2-((6-chloro-7-fluoro-2- methylquinazolin-4...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719769BDBM719769(2-hydroxy-N-((5-(2-((6- (trifluoromethyl)oxazolo[5...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719782BDBM719782(N-((5-(2-((6-(3,3- difluoropyrrolidin-1-yl)-2- met...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719783BDBM719783(2-hydroxy-N-((5-(2-((2-methyl-6- (4-methylpiperazi...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719780BDBM719780(2-hydroxy-N-((5-(2-((2-methyl-6- (piperidin-1-yl)q...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719781BDBM719781(2-hydroxy-N-((5-(2-((2-methyl-6- (1,4-oxazepan-4-y...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719778BDBM719778(2-hydroxy-N-((5-(2-((6-methoxy-2- (trifluoromethyl...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719779BDBM719779(2-hydroxy-N-((5-(2-((2-methyl-6- morpholinoquinazo...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719776BDBM719776(N-((5-(2-((6- ((cyclopropylmethyl)amino)-2- methyl...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719777BDBM719777(N-((5-(2-((2-cyclopropyl-6- (trifluoromethyl)-2H-p...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719758BDBM719758(2-hydroxy-N-((5-(2-((6-methoxy-2- methylquinazolin...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719759BDBM719759(2-hydroxy-N-((5-(2-((2-methyl-6- (trifluoromethyl)...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719754BDBM719754(N-((5-(2-((1-methyl-1H- pyrazolo[3,4-d]pyrimidin-4...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719764BDBM719764(2-hydroxy-N-((5-(2-((2- methylquinazolin-4- yl)thi...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719762BDBM719762(2-hydroxy-N-((5-(2-((2- methylpyrido[2,3-d]pyrimid...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719760BDBM719760(N-((5-(2-((2-ethylquinazolin-4- yl)thio)acetyl)thi...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719804BDBM719804(N-((5-(2-((6-cyclopropyl-2- methylquinazolin-4- yl...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719815BDBM719815(2-hydroxy-N-((5-(2-((5- (trifluoromethyl)oxazolo[5...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719812BDBM719812(2,2-difluoro-N-((5-(2-((2- (trifluoromethyl)pyrido...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719810BDBM719810(N-((5-(2-((7-cyclopropyl-2- (trifluoromethyl)pyraz...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719811BDBM719811(2-hydroxy-N-((5-(2-((2- (trifluoromethyl)pyrido[2,...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719796BDBM719796(N-(2-(5-(2-((2- (trifluoromethyl)quinazolin-4- yl)...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719797BDBM719797(N-((5-(2-((2- (trifluoromethyl) quinazolin-4- yl)t...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719838BDBM719838(2-hydroxy-N-((5-(2-((6-methoxy- 2-methylpyrido[2,3...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719836BDBM719836(4-((5-(2-((2- (trifluoromethyl)pyrido[2,3- d]pyrim...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719834BDBM719834(N-((5-(2-((1-ethyl-6- (trifluoromethyl)-1H-pyrazol...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719833BDBM719833(N-((5-(2-((2-ethyl-6- (trifluoromethyl)-2H-pyrazol...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719846BDBM719846(2-hydroxy-N-((5-(2-((8-methoxy- 2-methyl-6- (trifl...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719847BDBM719847(N-((5-(2-((6-(dimethylamino)-2- methylpyrido[3,4-d...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719844BDBM719844(N-((5-(2-((6-chloro-5-fluoro-2- methylquinazolin-4...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719845BDBM719845(N-((5-(2-((6-(2-oxa-5- azabicyclo[2.2.2]octan-5-yl...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719842BDBM719842(N-((5-(2-((6-ethoxy-2- methylquinazolin-4- yl)thio...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719843BDBM719843(N-((5-(2-((6-ethoxy-2- methylpyrido[3,4-d]pyrimidi...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719840BDBM719840(N-((5-(2-((6-chloro-8-fluoro-2- methylquinazolin-4...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719822BDBM719822(N-((5-(2-((6-fluoro-2- methylpyrido[2,3-d]pyrimidi...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719823BDBM719823(2-hydroxy-N-((5-(2-((1-(2- methoxyethyl)-6-(triflu...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719820BDBM719820(N-((5-(2-((2- (trifluoromethyl)pyrido[2,3- d]pyrim...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719821BDBM719821(2,2,2-trifluoro-N-((5-(2-((2- (trifluoromethyl)pyr...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719819BDBM719819(2-hydroxy-N-((5-(2-((6-methoxy- 2-methylpyrido[3,4...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719816BDBM719816(2-hydroxy-N-((5-(2-((6- (trifluoromethyl)oxazolo[4...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719817BDBM719817(2-hydroxy-N-((5-(2-((2-methyl-6- (trifluoromethyl)...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719830BDBM719830(2-hydroxy-N-((5-(2-((2-(2- methoxyethyl)-6-(triflu...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719831BDBM719831(N-((5-(2-((1-cyclopropyl-6- (trifluoromethyl)-1H-p...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719829BDBM719829(2-hydroxy-N-methyl-N-((5-(2-((2- (trifluoromethyl)...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719827BDBM719827((S)-2-hydroxy-N-(1-(5-(2-((6- (trifluoromethyl)oxa...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetHistone deacetylase 6 [482-800](Human)
Augustine Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 719824BDBM719824(2-hydroxy-N-((5-(2-((2-methyl-6- (trifluoromethoxy...)
Affinity DataIC50: 100nMAssay Description:NanoBRET target engagement was performed against the catalytic domain 2 (CD2) of HDAC6, with minor modifications of kit manufacturer protocol (Promeg...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

Displayed 1 to 50 (of 289 total ) | Next | Last >>
Jump to: